Literature DB >> 20877541

What's New in Fillers in 2010?

.   

Abstract

The number of products available to dermatologists for soft tissue augmentation has grown significantly over the past several years in the United States. This manuscript reviews the various hyaluronic acid fillers and other United States Food and Drug Administration-approved products utilized for patients in the rejuvenation process. It is the hope that through this paper, clinicians will feel more comfortable using these products in their everyday practice of dermatology.

Entities:  

Year:  2010        PMID: 20877541      PMCID: PMC2945864     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  31 in total

1.  Long-lasting results with hydroxylapatite (Radiesse) facial filler.

Authors:  Patricio F Jacovella; Claudia B Peiretti; Diego Cunille; Mauricio Salzamendi; Sophia Asiu Schechtel
Journal:  Plast Reconstr Surg       Date:  2006-09       Impact factor: 4.730

2.  Evaluation of injectable CaHA for the treatment of mid-face volume loss.

Authors:  Kenneth Beer; Monica Yohn; Joel L Cohen
Journal:  J Drugs Dermatol       Date:  2008-04       Impact factor: 2.114

3.  Injectable poly-l-lactic acid: 3 years of aesthetic experience.

Authors:  Nicholas J Lowe; C Anne Maxwell; Philippa Lowe; Ardash Shah; Rickie Patnaik
Journal:  Dermatol Surg       Date:  2009-02       Impact factor: 3.398

4.  Duration of correction for human immunodeficiency virus-associated lipoatrophy after retreatment with injectable poly-L-lactic acid.

Authors:  D R Mest; G M Humble
Journal:  Aesthetic Plast Surg       Date:  2008-08-14       Impact factor: 2.326

5.  Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial.

Authors:  Marion Michaela Moers-Carpi; Jaime Opi Tufet
Journal:  Dermatol Surg       Date:  2007-12-17       Impact factor: 3.398

6.  A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juvéderm injectable gel with and without lidocaine.

Authors:  Susan H Weinkle; David E Bank; Charles M Boyd; Michael H Gold; Jane A Thomas; Diane K Murphy
Journal:  J Cosmet Dermatol       Date:  2009-09       Impact factor: 2.696

Review 7.  Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.

Authors:  Kevin Christopher Smith
Journal:  Dermatol Online J       Date:  2008-08-15

8.  Controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite premixed with lidocaine for correction of nasolabial folds.

Authors:  Ellen Marmur; Lawrence Green; Mariano Busso
Journal:  Dermatol Surg       Date:  2010-01-19       Impact factor: 3.398

Review 9.  Hyaluronic acid gel (Juvéderm) preparations in the treatment of facial wrinkles and folds.

Authors:  Inja Bogdan Allemann; Leslie Baumann
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

Review 10.  Use of hyaluronic acid fillers for the treatment of the aging face.

Authors:  Michael H Gold
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more
  3 in total

1.  Comparative Analysis of Hyaluronidase-Mediated Degradation Among Seven Hyaluronic Acid Fillers in Hairless Mice.

Authors:  Seong Sung Kwak; Kwang Ho Yoon; Jin Hee Kwon; Won-Ho Kang; Chang-Hoon Rhee; Gi-Hyeok Yang; Deu John M Cruz; Woo-Chan Son
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-03-08

2.  A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips.

Authors:  Wolfgang G Philipp-Dormston; Said Hilton; Myooran Nathan
Journal:  J Cosmet Dermatol       Date:  2014-06       Impact factor: 2.696

Review 3.  A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers.

Authors:  Koenraad De Boulle; Richard Glogau; Taro Kono; Myooran Nathan; Ahmet Tezel; Jean-Xavier Roca-Martinez; Sumit Paliwal; Dimitrios Stroumpoulis
Journal:  Dermatol Surg       Date:  2013-08-13       Impact factor: 3.398

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.